Clinical Trial: Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma

U.S., May 14 -- ClinicalTrials.gov registry received information related to the study (NCT07585032) titled 'Safety and Efficacy of EUS-RFA in Pancreatic Insulinoma' on April 27.

Brief Summary: Transcutaneous and EUS-guided radiofrequency ablation are both modern modalities to apply in the managemnet of various malignancies.

In the current study the investigators aim to study the technical feasibility, patient safety and clinical efficacy of EUS-RFA for the treatment of pancreatic insulinoma.

Study Start Date: March 31, 2025

Study Type: OBSERVATIONAL

Condition: Insulinoma; Pancreas

Intervention: PROCEDURE: EUS-RFA

Treatment of insulinoma by EUS-RFA

Recruitment Status: RECRUITING

Sponsor: Sahlgrenska University Hospital

Informatio...